^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    OR2805

    i
    Other names: OR2805, OR 2805
    Associations
    News
    Trials
    Company:
    OncoResponse
    Drug class:
    CD163 inhibitor
    Associations
    News
    Trials